These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 14579280)

  • 21. Human iris pigment epithelial cells suppress T-cell activation via direct cell contact.
    Hattori T; Kezuka T; Usui Y; Okunuki Y; Takeuchi M; Maruyama K; Haneda M; Shirato S; Goto H
    Exp Eye Res; 2009 Sep; 89(3):358-64. PubMed ID: 19379738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.
    Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
    Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells.
    Schoop R; Wahl P; Le Hir M; Heemann U; Wang M; Wüthrich RP
    Nephrol Dial Transplant; 2004 Nov; 19(11):2713-20. PubMed ID: 15353579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
    Tsushima F; Iwai H; Otsuki N; Abe M; Hirose S; Yamazaki T; Akiba H; Yagita H; Takahashi Y; Omura K; Okumura K; Azuma M
    Eur J Immunol; 2003 Oct; 33(10):2773-82. PubMed ID: 14515261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-1 inhibits antiviral immunity at the effector phase in the liver.
    Iwai Y; Terawaki S; Ikegawa M; Okazaki T; Honjo T
    J Exp Med; 2003 Jul; 198(1):39-50. PubMed ID: 12847136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of cytolytic activity of human effector cells by transgenic expression of human PD-ligand-1 on porcine target cells.
    Plege A; Borns K; Beer L; Baars W; Klempnauer J; Schwinzer R
    Transpl Int; 2010 Dec; 23(12):1293-300. PubMed ID: 20579316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
    Wong M; La Cava A; Singh RP; Hahn BH
    J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoring function in exhausted CD8 T cells during chronic viral infection.
    Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
    Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.
    Eppihimer MJ; Gunn J; Freeman GJ; Greenfield EA; Chernova T; Erickson J; Leonard JP
    Microcirculation; 2002 Apr; 9(2):133-45. PubMed ID: 11932780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
    Terrazas LI; Montero D; Terrazas CA; Reyes JL; Rodríguez-Sosa M
    Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-L2 is expressed on activated human T cells and regulates their function.
    Messal N; Serriari NE; Pastor S; Nunès JA; Olive D
    Mol Immunol; 2011 Sep; 48(15-16):2214-9. PubMed ID: 21752471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.
    Liang SC; Latchman YE; Buhlmann JE; Tomczak MF; Horwitz BH; Freeman GJ; Sharpe AH
    Eur J Immunol; 2003 Oct; 33(10):2706-16. PubMed ID: 14515254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.
    Gotsman I; Grabie N; Dacosta R; Sukhova G; Sharpe A; Lichtman AH
    J Clin Invest; 2007 Oct; 117(10):2974-82. PubMed ID: 17853943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
    Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
    Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
    Sim JH; Park MJ; Park S; Lee ES
    Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.
    Kaiser AD; Schuster K; Gadiot J; Borkner L; Daebritz H; Schmitt C; Andreesen R; Blank C
    Eur J Immunol; 2012 Mar; 42(3):662-71. PubMed ID: 22144176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
    del Rio ML; Buhler L; Gibbons C; Tian J; Rodriguez-Barbosa JI
    Transpl Int; 2008 Nov; 21(11):1015-28. PubMed ID: 18662368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.